Stereotaxis' endovascular robotic system wins EU clearance

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the ...

12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Stereotaxis' endovascular robotic system wins EU clearance. The company has applied for 510(k) clearance from the FDA for its GenesisX system, ...

Stereotaxis's endovascular robotic system gains EU clearance

Stereotaxis's endovascular robotic system gains EU clearance ... The global market for robotic surgical systems and their accessories will reach ...

Stereotaxis' endovascular robotic system wins EU clearance

Stereotaxis' endovascular robotic system wins EU clearance. Phalguni Deswal. Tue, Aug 13, 2024 2 min read. Stereotaxis has received a CE mark in Europe for its ...

Stereotaxis earns CE mark for new surgical robot - MedTech Dive

Stereotaxis has secured Europe's CE mark for its latest robotic surgery system that is designed for easier installation, which the company hopes ...

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the ...

Obtained CE mark in Europe for GenesisX robotic system · Submitted 510(k) application to FDA for US clearance · GenesisX reduces hospital adoption ...

Stereotaxis (STXS) Achieves CE Mark in Europe for GenesisX

Stereotaxis STXS recently received a CE mark in Europe for GenesisX — a next-generation robotic system. The company also submitted a 510(k) ...

About Us - Stereotaxis

The GenesisX system is the latest iteration of ...

Stereotaxis Gets Key EU Clearance to Market GenesisX Robotic ...

Stereotaxis said its GenesisX robotic system obtained a CE mark in Europe, a designation signifying a product has been assessed to meet safety, ...

Stereotaxis wins CE mark for next-gen surgical robot, submits to FDA

The GenesisX surgical robot system. [Image courtesy of Stereotaxis] Stereotaxis (NYSE:STXS) announced that it obtained CE mark in Europe and ...

Stereotaxis wins updated CE mark for all devices available in Europe

Stereotaxis said it now has an updated EU Quality Management System Certificate. This demonstrates that the company falls in line with MDR and ...

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the ...

Latest innovation in Robotic Magnetic Navigation technology supports broad accessibility of robotics for minimally-invasive endovascular ...

Guided Solutions on LinkedIn: Stereotaxis' endovascular robotic ...

Guided Solutions' Post · Stereotaxis' endovascular robotic system wins EU clearance · More Relevant Posts · New products take center stage in medtech's latest ...

Stereotaxis GenesisX EU nod marks major shift in robotic-assisted ...

The EU clearance of Stereotaxis' endovascular robotic system “GenesisX” marks a significant advancement in the rapidly growing field of ...

Stereotaxis Reports 2024 Third Quarter Financial Results - Stock Titan

What regulatory approvals did Stereotaxis (STXS) receive in Q3 2024? ... Stereotaxis received CE Mark approval for the GenesisX robotic system in ...

Stereotaxis Announces Regulatory Submissions of the MAGiC ...

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that regulatory ...

Stereotaxis GenesisX cleared by EU - Clinical Services Journal

The EU clearance of Stereotaxis' endovascular robotic system “GenesisX” marks a significant advancement in the rapidly growing field of ...

Stereotaxis to acquire Access Point Technologies and its EP catheters

Stereotaxis is purchasing a Minneapolis-based EP catheter maker to further enhance its minimally invasive endovascular surgical robotics.

Stereotaxis Receives CE Mark Recertification Under EU's MDR ...

ST. LOUIS , May 24, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally ...

Stereotaxis Reports 2024 Third Quarter Financial Results - BioSpace

European CE Mark approval of the MAGiC ablation catheter is expected in the near future. Engagement with the FDA on the MAGiC PMA submission has ...